12
Participants
Start Date
October 4, 2021
Primary Completion Date
June 11, 2022
Study Completion Date
December 16, 2022
Psilocybin
Psilocybin is a classic psychedelic of medium duration that is well-tolerated and has a documented safety and efficacy record that makes it uniquely well-suited to the existential issues that arise in this patient population. Psilocybin has been described as an 'existential medicine' given patient testimonials as to its acute and lasting effects on interpersonal connection, ability to more deeply engage with meaningful activities and relationships, dramatic reductions in fear of death, and a renewed sense of well-being.
Huntsman Cancer Institute, Salt Lake City
Usona Institute
OTHER
University of Utah
OTHER